Filter
3918
Filtered Results: 3918
Text search:
ReAct
Featured
Recommendations
447
New Publications
933
Language
Document type
No document type
2221
Guidelines
580
Studies & Reports
492
Manuals
228
Fact sheets
124
Training Material
101
Strategic & Response Plan
88
Situation Updates
24
Infographics
20
Brochures
18
Resource Platforms
13
Online Courses
7
Videos
2
Countries / Regions
India
201
Global
116
South Africa
85
Western and Central Europe
80
Kenya
78
Nigeria
69
Ethiopia
68
Uganda
62
Tanzania
62
Sierra Leone
60
Liberia
59
Nepal
55
Zambia
52
Africa
48
Syria
45
Ghana
44
Latin America and the Carribbean
44
Congo, Democratic Republic of
41
Malawi
41
Rwanda
38
Bangladesh
35
Myanmar / Burma
31
Ukraine
30
Philippines
28
Zimbabwe
27
Eastern Europe
27
South–East Asia Region
26
Germany
24
Namibia
23
Lesotho
21
Senegal
19
Indonesia
19
Cambodia
18
West and Central Africa
18
Guinea
17
Mozambique
16
Brazil
16
Colombia
15
East and Southern Africa
15
Middle East and North Africa
15
Burkina Faso
14
Cameroon
14
South Sudan
13
Haiti
12
Argentina
12
Botswana
12
Venezuela
12
USA
11
Lebanon
11
Eswatini/ Swaziland
11
Asia
10
Madagascar
9
Western Pacific Region
9
Eastern Europe and Central Asia
9
Peru
8
Angola
8
Yemen
8
Russia
8
Pakistan
7
Afghanistan
7
Central African Republic
7
Somalia
6
Iraq
6
Jordan
6
Thailand
6
Benin
6
Georgia
6
Vietnam
6
Côte d’Ivoire / Ivory Coast
5
China
5
Bolivia
5
Chile
5
Mali
4
Chad
4
Sudan
4
Paraguay
4
Palestine
4
Niger
3
Togo
3
Ecuador
3
Libya
3
Sri Lanka
3
Moldova
3
United Kingdom
3
Spain
3
Guinea-Bissau
2
Saudi Arabia
2
Gambia
2
El Salvador
2
Greece
2
Guatemala
2
Mexico
2
Fiji
2
Bhutan
2
Albania
2
Southern Africa
2
Laos
2
Congo-Brazzaville
2
Canada
2
Timor Leste/ East Timor
2
Iran
2
Kazakhstan
2
North America
2
France
2
Tunisia
2
Morocco
1
Turkey
1
Egypt
1
Malaysia
1
Mauritania
1
Ireland
1
Singapore
1
Papua New Guinea
1
Dominican Republic
1
North Macedonia
1
Switzerland
1
Serbia
1
Croatia
1
Burundi
1
Honduras
1
Nicaragua
1
Other region
1
Solomon Islands
1
North Korea
1
Italy
1
Djibouti
1
Mongolia
1
Tajikistan
1
Kyrgyzstan
1
Australia
1
Gabon
1
Uruguay
1
Jamaica
1
Japan
1
Mauritius
1
Portugal
1
Morocco
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1255
Clinical Guidelines
405
Public Health
168
Key Resources
154
Women & Child Health
144
Capacity Building
107
Pharmacy & Technologies
68
Annual Report MEDBOX
3
Toolboxes
COVID-19
412
Mental Health
409
HIV
255
TB
248
NTDs
152
Rapid Response
150
AMR
149
Ebola
138
Pharmacy
113
Conflict
97
Caregiver
94
Refugee
93
Disability
89
Planetary Health
87
Natural Hazards
45
Zika
44
Specific Hazards
40
NCDs
38
Global Health Education
33
Polio
32
Cholera
27
Social Ethics
19
Health Financing Toolbox
18
Typhoon
1
Health Financing
1
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Revised and expanded version of the Guidelines
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
Schistosomiasis is a neglected tropical disease of global medical and veterinary importance. As efforts to eliminate schistosomiasis as a public health problem and interrupt transmission gather momentum, the potential zoonotic risk posed by livestock Schistosoma species via viable hybridisation in s...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
FIND and Standard Diagnostics (SD) have developed a lateral flow rapid diagnostic test (RDT) to screen for
T.b. gambiense HAT that is cheap and easy to use. The tests are packed individually and are stable at 40°C for
up to 25 months; they are performed on fresh blood obtained from a finger prick...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
This Handbook is primarily for educators, to help them learn about mental health issues and better support them in educational environments. The Handbook aims to provide training to teachers, administrators, and people involved in the education of primary school children about the implementation of ...
In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio...
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...
This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the...
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in achieving these goals globally. Men in high HIV burden settings and men from key populations in all settings are consistently less likely to know t...
Les pays progressent vers la réalisation de l’objectif mondial tendant à ce que, d’ici 2025, 95 pour cent des personnes qui vivent avec le VIH connaissent leur statut sérologique. Cependant, en 2020, on estimait encore à 6 millions le nombre de personnes séropositives non diagnostiquées da...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
